news & events
ysios news
21.10.20
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
28.09.20
Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline
18.09.20
LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs
15.09.20
ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio
08.07.20
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
07.07.20
CVRx® Raises $50 Million in New Equity Financing
16.06.20
Ona Therapeutics raises €30M in Series A financing
10.06.20
Ysios Capital presents its third fund of € 200M
04.12.19
Anaconda biomed secures €20 million round of funding
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
